-

$undefined

N/A

(N/A)

Cadrenal Therapeutics :CVKD

Location: | Industry: | Sector:

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

5.868M

Cash

5.037M

Avg Qtr Burn

-1.172M

Short % of Float

2.78%

Insider Ownership

46.72%

Institutional Own.

2.19%

Qtr Updated

06/30/24

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Tecarfarin Details End-Stage Renal Disease , Systemic thromboembolism, Atrial fibrillation	Phase 3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Tecarfarin Details Left Ventricular Assist Devices Patients	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.